Statins promote the growth of experimentally induced cerebral aneurysms in estrogen-deficient rats

Stroke. 2011 Aug;42(8):2286-93. doi: 10.1161/STROKEAHA.110.608034. Epub 2011 Jul 7.

Abstract

Background and purpose: The pathogenesis of cerebral aneurysms is linked to inflammation, degradation of the extracellular matrix, and vascular wall apoptosis. Statins exert pleiotropic effects on the vasculature, independent of their cholesterol-lowering properties. To explore the detailed pathogenesis of cerebral aneurysms, we examined their progression in a rat model and studied whether statins prevent their initiation and growth.

Methods: Cerebral aneurysms were induced in female rats subjected to hypertension, increased hemodynamic stress, and estrogen deficiency. The development of aneurysm was assessed morphologically on corrosion casts. The effects of pravastatin (5, 25, or 50 mg/kg per day) and of simvastatin (5 mg/kg per day) on their aneurysms were studied. Human brain endothelial cells were also used to determine the effects of pravastatin.

Results: Pravastatin (5 mg/kg per day) reduced endothelial damage and inhibited aneurysm formation; there was an association with increased endothelial nitric oxide synthase (eNOS) levels and a decrease in human brain endothelial cell adhesion molecules. Unexpectedly, 25 mg/kg per day and 50 mg/kg per day pravastatin and 5 mg/kg per day simvastatin promoted aneurysmal growth, and high-dose pravastatin induced aneurysmal rupture. The deleterious effects exerted by these statins were associated with an increase in apoptotic caspase-3 levels and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells, suggesting that statins exert bidirectional effects.

Conclusions: Our results provide the first evidence that cerebral aneurysm growth is partly associated with apoptosis and issue a warning that statins exert bidirectional effects on cerebral aneurysms. Additional intensive research is necessary to understand better their mechanisms and to identify patients in whom the administration of statins may elicit deleterious effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Brain / drug effects*
  • Brain / pathology*
  • Cells, Cultured
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Estrogens / deficiency*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • Hypertension / complications
  • Hypertension / metabolism
  • Hypertension / pathology
  • Intracranial Aneurysm / etiology
  • Intracranial Aneurysm / metabolism
  • Intracranial Aneurysm / pathology*
  • Nitric Oxide Synthase Type III / metabolism
  • Pravastatin / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Simvastatin / pharmacology*

Substances

  • Estrogens
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Simvastatin
  • Nitric Oxide Synthase Type III
  • Pravastatin